SMi is thrilled to announce the return of its 4th annual conference, Lyophilisation Europe, taking place on 4th and 5th July in London, UK. With the rising risk of contamination and the need for improved formulation methods of biological products, robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining drug quality and stability.

Innovation and efficiency is requested at every level making Lyophilisation Europe 2016, the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to a competitive growing industry.

Aimed at an audience of Senior Scientists and Heads of Pharmaceutical Engineering, Lyophilisation Europe 2016 will provide a focal point for the industry to discuss the latest advancements in pharmaceutical freeze drying, welcoming expertise from the likes of Boehringer Ingelheim, GSK and Sanofi.

GTCbio is proud to present the 3rd Metabolomics - Advances & Applications in Human Disease Conference, which will be part of The Genomics & Big Data Summit and takes place May 25-26, 2016 in Boston, MA.

There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in biomarker development, mass spectrometry-cased imaging, big data, and the application of metabolomics for drug discovery and development.

Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data

Sessions include:

I. Advances in Metabolite Markers - Discovery and Validation
II. Imaging and Computational Approaches to Assessing the Metabolome
III. Metabolite Identification - Targets and Pathways
IV. Bioinformatics for Metabolomics: Current Status and Future Directions
V. Translating Metabolomics Discoveries in Clinical Practice
We hope to see you there!

Conference Dates: May 25-26, 2016

Conference Link: http://www.gtcbio.com/metabolomics

On behalf of GTCbio and the 2016 Advisory Board, you are invited to the CRISPR & Genome Engineering Conference which takes place May 26-27, 2016 in Boston, MA. This meeting is part of The Genomics & Big Data Summit and will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss the most recent advances in CRISPR & Genome Engineering.

Leading researchers will present on hot topics such as: therapeutic applications of CRISPR and genome engineering, discovery and mechanisms of CRISPR systems, and will discuss updates on current CRISPR technologies and techniques. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how CRISPR & Genome

Engineering will continue to impact biomedical research.

Sessions include:

I. Therapeutic Applications of CRISPR & Genome Engineering
II. Advances in CRISPR-Cas9 Specificity
III. Discovery and Mechanisms of CRISPR Systems
IV. Update: Current CRISPR Technologies & Techniques
V. CRISPR Regulation of Gene Expression
We look forward to seeing you at the conference!

Conference Dates: May 26-27, 2016

Conference Link: http://www.gtcbio.com/CRISPR

SMi will present their inaugural conference on Alzheimer’s Disease 2016, which is one of the most threatening diseases that accompanies age, yet formidably mysterious in biology.

This conference will cover: Pre-clinical assessment criteria for AD diagnosis such as risk profiling, population group assessment and stages of AD progression. How do external stimuli play influence studies and outcome?

Furthermore, emerging frontiers in biomarker development to aid more accurate diagnosis and tracking of tau-mediated neuronal death will help further drug development as well as providing more answers into how AD occurs, and most importantly when.

The conference will gather leading researchers and clinical managers to discuss models, diagnostic imaging and novel therapeutic platforms.

For more info visit: http://www.alzheimers-conference.com/bioscreening

SMi Group are thrilled to present the 2nd annual Lyophilization USA conference, returning to Iselin, New Jersey on April 27th & 28th 2016.
 

With an increase in contract services, combination products and innovative drug delivery devices, growing demand for lyophilization equipment and lyophilized biopharmaceuticals has contributed to a projected rise in market growth from US $2.0 billion in 2013 to US $4.8 billion by 2020.
 

While pharmaceutical companies are still dedicating research efforts on freeze drying technologies, commerciality of scaling up and homogeneity of product quality remain top concerns.
 

Lyophilization USA 2016 will gather leading market experts to discuss the latest cutting edge developments in freeze drying as well as solutions to on-going industry challenges. The packed agenda features a mix of case study led presentations, panel debates, interactive workshops and keynote addresses that have been tailored for an audience of professionals working in pharmaceutical lyophilization from formulation development through to production and quality assurance.
 

Featured Speakers Include:

• Jim Searles, Technical Fellow, Global Technical Services, Pfizer

• Mark Yang, Director, Genzyme

• Evgenyi Shalaev, Research Investigator, Allergan

• Sune Andersen, Principal Scientist Drying Processes, Novo Nordisk A / S

• Vineet Kumar, Senior Scientist, Johnson & Johnson

• Ralph Tarantino, Pharmaceutical Consultant & Principal, Steritech Solutions LLC

• Stuart Wang, Senior Scientist, Protein Process Development, Biogen Idec

• Jamie Tsung, Principal Scientist, Momenta Pharmaceuticals

Why You Should Attend:

• Define CQAs and QbD for a smooth lyophilization program – bridging upstream and downstream

• Learn about new technologies to accelerate lyophilization process and stabilize complex biologics products

• Thrive on product quality control and assurance during mass production and tech transfer

• ‘Dry fast and smart’ – develop a commercially viable lyophilization cycle

• Benchmark your strategies against peers’ and industry experts’ to ensure a sustainable drug development program and pipeline

Register online at http://www.lyophilization-usa.com/bioscreening